drugset / Trial / NCT03905486
Efficacy of Pregabalin Versus Combined Pregabalin and Milnacipran in Fibromyalgia.
RandomizedParallel-groupOpen-labelTreatment
Summary
Diagnosis of fibromyalgia is complex and treatment options are limited. Pharmacological management of fibromyalgia is mainly centered on the central nervous system. In particular there is robust evidence for the use of tricyclic antidepressants (e.g., amitriptyline), anti-convulsants such as gabapentin or pregabalin and agents from the serotonin norepinephrine reuptake inhibitor (SNRI) family such as milnacipran. Aim of the work: To compare the efficacy of pregabalin agent (averopreg) alone versus combined pregabalin and serotonin norepinephrine reuptake inhibitor (milnacipran) in the management of fibromyalgia.
Timeline
- Start
- 2019-04-01
- Primary completion
- 2019-11-30
- Completion
- 2019-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Milnacipran | Other / unclassified | 100 mg | — |
| Comparator | Pregabalin | Small molecule | 300 mg | — |